Genmab A/S GE9
$247.06
▼ -1.34% 24H
About
Genmab A/S is a biotechnology company headquartered in Copenhagen, Denmark, specializing in the discovery and development of antibody-based therapeutics primarily for cancer and other serious diseases. Founded in 1998, it focuses on innovative human antibody technologies to create differentiated products that address u…
SectorHealthcare
ExchangeXETR
IndustryBiotechnology
CountryDenmark
Employees2,639
TickerGE9
Statistics
Market Cap$15.17B
Revenue (TTM)$4.53B
Net Income—
Net Margin—
EPS—
P/E18.72
P/S3.35
P/B2.66
EV/EBITDA12.83
ROE15.0%
Dividend Yield—
Price$247.06
Data: Twelve Data · Revenue = mcap / P/S